Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Health collaborations forged at CIIE begin to bear fruit

By ZHOU WENTING in Shanghai | China Daily | Updated: 2021-01-19 10:10
Share
Share - WeChat
The stall of Novo Nordisk at the third China International Import Expo in Shanghai. [Photo/Xinhua]

Medical procedures, drugs, online programs serve patients, public across country

Two months after the third China International Import Expo ended in Shanghai, some exhibitors from the healthcare sector have disclosed that collaborations forged during the event have now materialized in the form of new drugs, innovative systems and technologies benefiting patients and the general public.

It transpires that several agreements were clinched between pharmaceutical multinationals and local healthcare authorities, institutions, schools and enterprises during the third CIIE.

Their partnerships' objective is to exploit inherent advantages and synergies in order to make the healthcare ecosystem in the country more innovative.

Executives of US-headquartered Boston Scientific said they had forged a strategic collaboration with Vivolight, a medical imaging device and technology provider based in Shenzhen, Guangdong province, during the third CIIE.

Their partnership may help drive improved clinical outcomes and technological progress in percutaneous coronary intervention, or PCI, procedures at hospitals.

This is said to be the first-ever strategic cooperation between a foreign enterprise and a local counterpart in the field of coronary intervention imaging.

The collaboration combines Boston Scientific's advantage in intravascular ultrasound and Vivolight's competitiveness in optical coherence tomography to provide patients with more accurate medical solutions for better treatment.

Experts said PCI procedures guided by imaging techniques such as IVUS and vascular OCT can significantly reduce the incidence of serious adverse events by making up for the lack of coronary angiography.

Industry experts said IVUS applied in intervention has been regarded as the "gold standard" in accordance with guidance from Europe and the United States.

However, in China, only 8 percent of PCI procedures are guided by imaging techniques, which compares with 15 percent in the US and more than 90 percent in Japan.

"For Boston Scientific, an important impetus of continuous growth in the China market is to collaborate with local partners to satisfy more local patients' unmet needs through diversified innovative channels," the company said in a written reply.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 亚洲精品国产成人| 最新中文字幕在线观看| 国产视频一区二区三区四区| 亚洲国产精品久久久久秋霞小| 美女胸被狂揉扒开吃奶二次元| 国产精品国产高清国产av| 三年片韩国在线观看| 日韩高清国产一区在线| 亚洲精品国精品久久99热| 自拍偷拍国语对白| 在线观看黄色一级片| 久久久噜噜噜久久熟女AA片| 精品免费久久久久久成人影院| 国产欧美一区二区精品久久久| juy031白木优子中文字幕| 无码成人AAAAA毛片| 亚洲三级在线播放| 特级aaaaaaaaa毛片免费视频| 国产99久久久国产精品~~牛| 免费看男女下面日出水来| 国产黄色片在线播放| 一级毛片一级毛片一级毛片| 欧美日韩无线码在线观看| 午夜亚洲乱码伦小说区69堂| 538在线视频| 妇女被猛烈进入在线播放| 久久国产精品2020盗摄| 欧美成人一区二区三区在线观看| 免费人成在线观看网站品爱网| 草莓视频网站入口| 国产欧美亚洲精品| 5g影院天天爽爽| 天天澡天天摸天天爽免费| 中文字幕一区二区三区日韩精品| 日韩在线一区二区三区免费视频 | 乱人伦人妻中文字幕| 毛片免费观看视频| 国产在线视频www色| 亚欧色一区w666天堂| 69堂国产成人精品视频不卡| 少妇高潮无套内谢|